RxNorm Mapping Clinical Concepts
The product Recelltis (NDC 71929-070) is cross-mapped to the RxNorm terminology system to ensure clinical interoperability. This formulation is linked to a unique clinical concept (RxCUI 2001994). By anchoring Cellnovation Technology's product data to these standardized identifiers, healthcare systems can maintain accurate medication records, safely automate e-prescribing, and streamline pharmacy workflows.
The following clinical concept cards detail the semantic term types (TTY), prescribable names, and synonymous clinical strings as defined by the National Library of Medicine (NLM).
Type
Clinical Name / Synonym
RxCUI
Details
Featured Concept
bacitracin zinc 0.4 UNT/ML / lidocaine hydrochloride 0.02 MG/ML / neomycin 0.0035 MG/ML / polymyxin B 5 UNT/ML Topical Cream
(RxCUI 2001994)
Semantic Clinical Drug
Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
Understanding RxNorm Mapping for Recelltis Wound Cream
RxNorm is a normalized naming system developed by the National Library of Medicine (NLM) to bridge the gap between different drug terminologies. By mapping NDC 71929-070 to RxCUI 2001994, this page provides the standardized "source of truth" required for hospital systems, e-prescribing software, and pharmacy benefit managers (PBMs) to communicate without errors.
Term Type (TTY) Legend for This Page
The clinical cards above utilize specific Term Types (TTY) to define the granularity of the drug concept:
-
PSN
Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
-
SCD
Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
-
SY
Synonym: An alternative clinical name or alias provided for search and retrieval clarity.
* Please review the full disclaimer at the bottom of this page.